- P = Professional
- B = Behavioral health
- F = Facilities
Pharmacy
P B F
Jul 1, 2024
Net Results UpdateThis information is effective as of July 1, 2024, and applies to all commercial em...
P
Jun 1, 2024
Fluticasone HFA has been added to all BCBSRI commercial formularies as a preferred tier medication.&...
P F
May 1, 2024
Fluticasone HFA has been added to all BCBSRI commercial formularies as a preferred tier medication.&...
P F
Apr 18, 2024
Fluticasone HFA has been added to all BCBSRI commercial formularies as a preferred tier medication.&...
P B F
Apr 1, 2024
Large Group and Small Group Markets FormularyThe information below is effective as of April 1, 2024 ...
P F
Mar 1, 2024
Please note Avastin (J9035) does require Prior Authorization to be reviewed by Prime for Medicare me...
P
Feb 15, 2024
If you have a patient with Covid-19 who is in one of our Medicare Advantage plans and you prescribe ...
P F
Mar 1, 2023
For NEHP members with a RI PCP, inquiries regarding medical drugs should be directed to the member’s...
P F
Feb 6, 2023
For NEHP members with a RI PCP, inquiries regarding medical drugs should be directed to the member’s...
P B F
Jan 1, 2023
The Inflation Reduction Act (IRA) will take effect on January 1, 2023.The Act includes the following...
P
Jan 1, 2023
As a reminder effective January 1, 2023, BCBSRI will cover the infliximab biosimilar products, Avsol...
P F
Jan 1, 2023
As part of our ongoing efforts to make high-quality and affordable healthcare available to our membe...
P F
Jan 1, 2023
Biosimilars: Are They the Same Quality?
Use this infographic from the FDA to talk with your patient...
P F
Dec 7, 2022
The Inflation Reduction Act (IRA) will take effect on January 1, 2023.The Act includes the following...
P F
Dec 1, 2022
Effective January 1, 2023, BCBSRI will cover the infliximab biosimilar products, Avsola and Inflectr...
P
Nov 1, 2022
Effective January 1, 2023, BCBSRI will cover the infliximab biosimilar products, Avsola and Inflectr...
P B F
Oct 1, 2022
Large Group and Small Group Markets Formulary
The information on the above linked page is effective...
P
Aug 1, 2022
As part of our ongoing efforts to make high-quality and affordable healthcare available to our membe...
P F
Aug 1, 2022
As part of our ongoing efforts to make high-quality and affordable healthcare available to our membe...
P F
Apr 1, 2022
As part of our ongoing efforts to make high-quality and affordable healthcare available to our membe...
P
Mar 1, 2022
The first interchangeable biosimilar insulin product has been approved by the FDA. Viatris has relea...
P F
Feb 4, 2022
As part of our ongoing efforts to make high-quality and affordable healthcare available to our membe...
P
Jan 1, 2022
The information below is effective as of January 1, 2022 and applies only to the individual market s...
P B F
Jan 1, 2022
Non-specialty pharmacy
A new preferred home delivery pharmacy and/or a new option for certain membe...